Skip to content
← Full study record

NCT01344018 · OUTCOME

Perioperative Complications

Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma · Source last updated 2023-04-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
From the date of surgery, up to 60 days following surgery

What was measured

Adverse events and side effects possibly related to surgery were assessed according to the Dindo's classification. This scales the observed side effects as Grade 0 No event Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Grade III Requiring surgical, endoscopic or radiological intervention Grade IV Life-threatening complication (including CNS complications) requiring IC/ICU-management Grade V Death of a patient For each item, the frequency of the worst grade of the observed toxicity was tabulated by treatment group. The perioperative period commence at the time of surgery (at the time of the induction anaesthesia) to the complete closure of the wound.

Analysis population: all randomized patients who are eligible and have started their allocated treatment (at least have been operated or received one fraction of irradiation followed by surgery)

Groups in this outcome

Surgery Alone

En-bloc resection of surrounding tissues and organs when located within 1 to 2 cm from the surface tumor, even when not infiltrated. therapeutic conventional surgery

Preoperative Radiotherapy Followed by En-bloc Surgery

3D-CRT or IMRT to a dose of 50.4 Gy/28 daily fractions therapeutic conventional surgery 3-dimensional conformal radiation therapy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Surgery Alone128
Preoperative Radiotherapy Followed by En-bloc Surgery119

Reported measurements

Source class 1

Dindo scale Grade 0

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Surgery Alone57Not reportedNot reportedNot reportedNot reported
Preoperative Radiotherapy Followed by En-bloc Surgery34Not reportedNot reportedNot reportedNot reported

Dindo scale Grade 1-2

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Surgery Alone57Not reportedNot reportedNot reportedNot reported
Preoperative Radiotherapy Followed by En-bloc Surgery58Not reportedNot reportedNot reportedNot reported

Dindo scale Grade 3

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Surgery Alone13Not reportedNot reportedNot reportedNot reported
Preoperative Radiotherapy Followed by En-bloc Surgery24Not reportedNot reportedNot reportedNot reported

Dindo scale Grade 4

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Surgery Alone1Not reportedNot reportedNot reportedNot reported
Preoperative Radiotherapy Followed by En-bloc Surgery2Not reportedNot reportedNot reportedNot reported

Dindo scale Grade 5

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Surgery Alone0Not reportedNot reportedNot reportedNot reported
Preoperative Radiotherapy Followed by En-bloc Surgery1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        57
      2. group Id
        OG001
        value
        34
      title
      Dindo scale Grade 0
    2. measurements
      1. group Id
        OG000
        value
        57
      2. group Id
        OG001
        value
        58
      title
      Dindo scale Grade 1-2
    3. measurements
      1. group Id
        OG000
        value
        13
      2. group Id
        OG001
        value
        24
      title
      Dindo scale Grade 3
    4. measurements
      1. group Id
        OG000
        value
        1
      2. group Id
        OG001
        value
        2
      title
      Dindo scale Grade 4
    5. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        1
      title
      Dindo scale Grade 5
denoms
  1. counts
    1. group Id
      OG000
      value
      128
    2. group Id
      OG001
      value
      119
    units
    Participants
description
Adverse events and side effects possibly related to surgery were assessed according to the Dindo's classification. This scales the observed side effects as Grade 0 No event Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Grade III Requiring surgical, endoscopic or radiological intervention Grade IV Life-threatening complication (including CNS complications) requiring IC/ICU-management Grade V Death of a patient For each item, the frequency of the worst grade of the observed toxicity was tabulated by treatment group. The perioperative period commence at the time of surgery (at the time of the induction anaesthesia) to the complete closure of the wound.
groups
  1. description
    En-bloc resection of surrounding tissues and organs when located within 1 to 2 cm from the surface tumor, even when not infiltrated. therapeutic conventional surgery
    id
    OG000
    title
    Surgery Alone
  2. description
    3D-CRT or IMRT to a dose of 50.4 Gy/28 daily fractions therapeutic conventional surgery 3-dimensional conformal radiation therapy
    id
    OG001
    title
    Preoperative Radiotherapy Followed by En-bloc Surgery
param Type
COUNT_OF_PARTICIPANTS
population Description
all randomized patients who are eligible and have started their allocated treatment (at least have been operated or received one fraction of irradiation followed by surgery)
reporting Status
POSTED
time Frame
From the date of surgery, up to 60 days following surgery
title
Perioperative Complications
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice